Drug companies and their allies over the past year have filed a slew of lawsuits challenging the Medicare drug-price ... U.S.

The advisor alleges that company policies degraded his ability to serve clients. One provision bars him from contacting past, present and potential clients for two years post-employment. Felix ...

The Harris campaign website said the vice president is committed to bringing down drug prices "by taking on pharmacy ...

The program selected the first 10 ... It's expected Medicare drug price negotiations will save the government $98.5 billion over a decade, according to the Congressional Budget Office, which ...

President Biden headlined the first night on Monday with a speech touting that “we finally beat Big Pharma” with Medicare drug price negotiation. Vice President Harris is slated to speak ...

But the pharmaceutical industry has decried the effort as “price setting” that will over time become a drag on drug research and ... to define her own economic program independent of Biden ...

Chambers of commerce exist all over the world ... may or may not be affiliated with the U.S. Chamber of Commerce through a Federation Partnership Program. The national chamber tends to support ...

The negotiated rates represent a savings from 38 percent to 79 percent over the 2023 list prices of the drugs, which were some of the priciest in Medicare. But Medicare doesn’t pay the full list ...

As a result of the Price Negotiation Program and the drug pricing changes to be expected over the next few years, health plans are encouraged to review closely the financial terms of their ...

He dismissed accusations that Novo Nordisk operates as a drug cartel as “unfounded.” Also Read: Novo Nordisk’s Ozempic Might Be Among 2027 Medicare Price Negotiation Targets. Jørgensen’s ...

Frank Pallone, D-N.J., who is the ranking Democrat on the House Energy & Commerce ... program does not take aim at pharmacy benefit managers. PBMs, pharma play blame game over drug pricing at ...

Previously, the U.S. government was not permitted to negotiate with Big Pharma over drug prices, though private ... challenging the premium stabilization program, alleging that it should have ...